✦ LIBER ✦

Second surgery for recurrent glioblastoma: advantages and pitfalls

✍ Scribed by Brandes, Alba A ;Bartolotti, Marco ;Franceschi, Enrico

Book ID: 120369059
Publisher: Expert Reviews
Year: 2013
Tongue: English
Weight: 826 KB
Volume: 13
Category: Article
ISSN: 1473-7140
DOI: 10.1586/era.13.32

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

8705 Change in MGMT methylation status b

8705 Change in MGMT methylation status between first surgery for newly diagnosed glioblastoma and second surgery for recurrence: clinical implications

✍ Brandes, A.; Franceschi, E.; Tosoni, A.; Fioravanti, A.; Agati, R.; Andreoli, A. 📂 Article 📅 2009 🏛 Elsevier Science 🌐 English ⚖ 51 KB

Advantages of laparoscope-assisted surge

Advantages of laparoscope-assisted surgery for recurrent Crohn disease

✍ F. Uchikoshi; T. Ito; R. Nezu; M. Tanemura; Y. Kai; T. Mizushima; K. Nakajima; H 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 436 KB

Advantages of laparoscope-assisted surge

Advantages of laparoscope-assisted surgery for recurrent Crohn's disease

✍ F. Uchikoshi; T. Ito; R. Nezu; M. Tanemura; Y. Kai; T. Mizushima; K. Nakajima; H 📂 Article 📅 2004 🏛 Springer 🌐 English ⚖ 84 KB

Immunotherapy Trials for Glioblastoma Mu

Immunotherapy Trials for Glioblastoma Multiforme: Promise and Pitfalls

✍ Raymund L. Yong; Russell R. Lonser 📂 Article 📅 2012 🏛 Elsevier 🌐 English ⚖ 716 KB

Surgery Insight: advantages and pitfalls

Surgery Insight: advantages and pitfalls of surgical techniques for the correction of bladder exstrophy

✍ Husmann, Douglas A 📂 Article 📅 2006 🏛 Nature Publishing Group 🌐 English ⚖ 130 KB

Bevacizumab and daily temozolomide for r

Bevacizumab and daily temozolomide for recurrent glioblastoma

✍ Annick Desjardins; David A. Reardon; April Coan; Jennifer Marcello; James E. Her 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 1021 KB

## Abstract ## BACKGROUND: The authors performed a phase 2 trial of combined protracted daily temozolomide and biweekly bevacizumab for patients with recurrent glioblastoma who had previously received radiation therapy and temozolomide. ## METHODS: There was no limit on the number of previous di